ID   BCL2_RAT                Reviewed;         236 AA.
AC   P49950; Q62837; Q64032;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 2.
DT   02-OCT-2024, entry version 171.
DE   RecName: Full=Apoptosis regulator Bcl-2;
GN   Name=Bcl2; Synonyms=Bcl-2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=8144041; DOI=10.1016/0378-1119(94)90561-4;
RA   Sato T., Irie S., Krajewski S., Reed J.C.;
RT   "Cloning and sequencing of a cDNA encoding the rat Bcl-2 protein.";
RL   Gene 140:291-292(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Ovary;
RX   PubMed=7828536; DOI=10.1210/endo.136.1.7828536;
RA   Tilly J.L., Tilly K.I., Kenton M.L., Johnson A.L.;
RT   "Expression of members of the Bcl-2 gene family in the immature rat ovary:
RT   equine chorionic gonadotropin-mediated inhibition of granulosa cell
RT   apoptosis is associated with decreased Bax and constitutive Bcl-2 and Bcl-
RT   xlong messenger ribonucleic acid levels.";
RL   Endocrinology 136:232-241(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 19-172.
RX   PubMed=7969891; DOI=10.1016/0306-4522(94)90069-8;
RA   Castren E., Ohga Y., Berzaghi M.P., Tzimagiorgis G., Thoenen H.,
RA   Lindholm D.;
RT   "bcl-2 messenger RNA is localized in neurons of the developing and adult
RT   rat brain.";
RL   Neuroscience 61:165-177(1994).
RN   [4]
RP   INTERACTION WITH PPIF.
RX   PubMed=19228691; DOI=10.1074/jbc.m808750200;
RA   Eliseev R.A., Malecki J., Lester T., Zhang Y., Humphrey J., Gunter T.E.;
RT   "Cyclophilin D interacts with Bcl2 and exerts an anti-apoptotic effect.";
RL   J. Biol. Chem. 284:9692-9699(2009).
RN   [5]
RP   INDUCTION BY LIPOPOLYSACCHARIDES.
RX   PubMed=30980393; DOI=10.1002/jcp.28614;
RA   Chao C.N., Lai C.H., Badrealam K.F., Lo J.F., Shen C.Y., Chen C.H.,
RA   Chen R.J., Viswanadha V.P., Kuo W.W., Huang C.Y.;
RT   "CHIP attenuates lipopolysaccharide-induced cardiac hypertrophy and
RT   apoptosis by promoting NFATc3 proteasomal degradation.";
RL   J. Cell. Physiol. 234:20128-20138(2019).
CC   -!- FUNCTION: Suppresses apoptosis in a variety of cell systems including
CC       factor-dependent lymphohematopoietic and neural cells. Regulates cell
CC       death by controlling the mitochondrial membrane permeability. Appears
CC       to function in a feedback loop system with caspases. Inhibits caspase
CC       activity either by preventing the release of cytochrome c from the
CC       mitochondria and/or by binding to the apoptosis-activating factor
CC       (APAF-1). Also acts as an inhibitor of autophagy: interacts with BECN1
CC       and AMBRA1 during non-starvation conditions and inhibits their
CC       autophagy function. May attenuate inflammation by impairing NLRP1-
CC       inflammasome activation, hence CASP1 activation and IL1B release.
CC       {ECO:0000250|UniProtKB:P10415}.
CC   -!- SUBUNIT: Forms homodimers, and heterodimers with BAX, BAD, BAK and Bcl-
CC       X(L). Heterodimerization with BAX requires intact BH1 and BH2 motifs,
CC       and is necessary for anti-apoptotic activity (By similarity). Component
CC       of the complex, at least composed of LRPPRC, BECN1 and BCL2; the
CC       interactions prevent BECN1 from forming an autophagy-inducing complex
CC       with PIK3C3 (By similarity). Interacts with EI24 (By similarity). Also
CC       interacts with APAF1, BBC3, BCL2L1, BNIPL, MRPL41 and TP53BP2. Binding
CC       to FKBP8 seems to target BCL2 to the mitochondria and probably
CC       interferes with the binding of BCL2 to its targets. Interacts with BAG1
CC       in an ATP-dependent manner. Interacts with RAF1 (the 'Ser-338' and
CC       'Ser-339' phosphorylated form). Interacts (via the BH4 domain) with
CC       EGLN3; the interaction prevents the formation of the BAX-BCL2 complex
CC       and inhibits the anti-apoptotic activity of BCL2. Interacts with G0S2;
CC       this interaction also prevents the formation of the anti-apoptotic BAX-
CC       BCL2 complex. Interacts with RTL10/BOP. Interacts with the SCF(FBXO10)
CC       complex. Interacts (via the loop between motifs BH4 and BH3) with NLRP1
CC       (via LRR repeats), but not with NLRP2, NLRP3, NLRP4, PYCARD, nor MEFV
CC       (By similarity). Interacts with GIMAP3/IAN4, GIMAP4/IAN1 and
CC       GIMAP5/IAN5 (By similarity). Interacts with BCAP31. Interacts with
CC       IRF3; the interaction is inhibited by Sendai virus infection. Interacts
CC       with BECN1; thereby inhibiting autophagy in non-starvation conditions.
CC       Interacts with AMBRA1; thereby inhibiting autophagy (By similarity).
CC       {ECO:0000250|UniProtKB:P10415, ECO:0000250|UniProtKB:P10417}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion outer membrane
CC       {ECO:0000250|UniProtKB:P10415}; Single-pass membrane protein
CC       {ECO:0000255}. Nucleus membrane {ECO:0000250|UniProtKB:P10415}; Single-
CC       pass membrane protein {ECO:0000255}. Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:P10415}; Single-pass membrane protein
CC       {ECO:0000255}. Cytoplasm {ECO:0000250|UniProtKB:P10417}.
CC   -!- TISSUE SPECIFICITY: Expressed in a variety of tissues, with highest
CC       levels in reproductive tissues. In the adult brain, expression is
CC       localized in mitral cells of the olfactory bulb, granule and pyramidal
CC       neurons of hippocampus, pontine nuclei, cerebellar granule neurons, and
CC       in ependymal cells. In prenatal brain, expression is higher and
CC       localized in the neuroepithelium and in the cortical plate.
CC   -!- INDUCTION: Down-regulated by lipopolysaccharides.
CC       {ECO:0000269|PubMed:30980393}.
CC   -!- DOMAIN: The BH4 motif is required for anti-apoptotic activity and for
CC       interaction with RAF1 and EGLN3. {ECO:0000250}.
CC   -!- DOMAIN: BH1 and BH2 domains are required for the interaction with BAX
CC       and for anti-apoptotic activity. {ECO:0000250|UniProtKB:P10415}.
CC   -!- DOMAIN: The loop between motifs BH4 and BH3 is required for the
CC       interaction with NLRP1. {ECO:0000250|UniProtKB:P10415}.
CC   -!- DOMAIN: The BH3 motif is required for XIAP-mediated ubiquitination and
CC       subsequent induction of apoptosis. {ECO:0000250|UniProtKB:P10415}.
CC   -!- PTM: Phosphorylation/dephosphorylation on Ser-70 regulates anti-
CC       apoptotic activity. Growth factor-stimulated phosphorylation on Ser-70
CC       by PKC is required for the anti-apoptosis activity and occurs during
CC       the G2/M phase of the cell cycle. In the absence of growth factors,
CC       BCL2 appears to be phosphorylated by other protein kinases such as ERKs
CC       and stress-activated kinases. Phosphorylated by MAPK8/JNK1 at Thr-69,
CC       Ser-70 and Ser-84, which stimulates starvation-induced autophagy (By
CC       similarity). Dephosphorylated by protein phosphatase 2A (PP2A) (By
CC       similarity). {ECO:0000250|UniProtKB:P10415,
CC       ECO:0000250|UniProtKB:P10417}.
CC   -!- PTM: Proteolytically cleaved by caspases during apoptosis. The cleaved
CC       protein, lacking the BH4 motif, has pro-apoptotic activity, causes the
CC       release of cytochrome c into the cytosol promoting further caspase
CC       activity (By similarity). {ECO:0000250|UniProtKB:P10415}.
CC   -!- PTM: Monoubiquitinated by PRKN, leading to an increase in its
CC       stability. Ubiquitinated by SCF(FBXO10), leading to its degradation by
CC       the proteasome. {ECO:0000250|UniProtKB:P10415}.
CC   -!- SIMILARITY: Belongs to the Bcl-2 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L14680; AAA53662.1; -; mRNA.
DR   EMBL; U34964; AAA77687.1; -; mRNA.
DR   EMBL; S74122; -; NOT_ANNOTATED_CDS; mRNA.
DR   PIR; I53744; I53744.
DR   PIR; I67432; I67432.
DR   RefSeq; NP_058689.1; NM_016993.1.
DR   AlphaFoldDB; P49950; -.
DR   SMR; P49950; -.
DR   BioGRID; 246412; 1.
DR   ComplexPortal; CPX-2018; BCL-2 dimer.
DR   ComplexPortal; CPX-2020; BAD:BCL-2 complex.
DR   ComplexPortal; CPX-2023; BID:BCL-2 complex.
DR   ComplexPortal; CPX-2028; PUMA:BCL-2 complex.
DR   ComplexPortal; CPX-2035; BIM:BCL-2 complex.
DR   DIP; DIP-30849N; -.
DR   IntAct; P49950; 3.
DR   STRING; 10116.ENSRNOP00000003768; -.
DR   iPTMnet; P49950; -.
DR   PhosphoSitePlus; P49950; -.
DR   PaxDb; 10116-ENSRNOP00000003768; -.
DR   GeneID; 24224; -.
DR   KEGG; rno:24224; -.
DR   UCSC; RGD:2199; rat.
DR   AGR; RGD:2199; -.
DR   CTD; 596; -.
DR   RGD; 2199; Bcl2.
DR   eggNOG; KOG4728; Eukaryota.
DR   InParanoid; P49950; -.
DR   OrthoDB; 4028889at2759; -.
DR   PhylomeDB; P49950; -.
DR   PRO; PR:P49950; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0097138; C:BAD-BCL-2 complex; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; ISS:UniProtKB.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0030061; C:mitochondrial crista; IDA:CACAO.
DR   GO; GO:0031966; C:mitochondrial membrane; ISO:RGD.
DR   GO; GO:0005741; C:mitochondrial outer membrane; ISS:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; ISO:RGD.
DR   GO; GO:0043209; C:myelin sheath; ISO:RGD.
DR   GO; GO:0031965; C:nuclear membrane; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:RGD.
DR   GO; GO:0046930; C:pore complex; ISO:RGD.
DR   GO; GO:0032991; C:protein-containing complex; ISO:RGD.
DR   GO; GO:0051400; F:BH domain binding; IPI:RGD.
DR   GO; GO:0051434; F:BH3 domain binding; ISO:RGD.
DR   GO; GO:0015267; F:channel activity; ISO:RGD.
DR   GO; GO:0016248; F:channel inhibitor activity; ISO:RGD.
DR   GO; GO:0140297; F:DNA-binding transcription factor binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0060090; F:molecular adaptor activity; ISO:RGD.
DR   GO; GO:0002020; F:protease binding; ISO:RGD.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISO:RGD.
DR   GO; GO:0051721; F:protein phosphatase 2A binding; ISO:RGD.
DR   GO; GO:0019903; F:protein phosphatase binding; ISO:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:RGD.
DR   GO; GO:0043565; F:sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; ISO:RGD.
DR   GO; GO:0007015; P:actin filament organization; ISO:RGD.
DR   GO; GO:0009887; P:animal organ morphogenesis; ISO:RGD.
DR   GO; GO:0008637; P:apoptotic mitochondrial changes; ISO:RGD.
DR   GO; GO:0006915; P:apoptotic process; ISO:RGD.
DR   GO; GO:0006914; P:autophagy; IEA:UniProtKB-KW.
DR   GO; GO:0031103; P:axon regeneration; ISO:RGD.
DR   GO; GO:0007409; P:axonogenesis; ISO:RGD.
DR   GO; GO:0001783; P:B cell apoptotic process; ISO:RGD.
DR   GO; GO:0030183; P:B cell differentiation; ISO:RGD.
DR   GO; GO:0001782; P:B cell homeostasis; ISO:RGD.
DR   GO; GO:0002326; P:B cell lineage commitment; ISO:RGD.
DR   GO; GO:0042100; P:B cell proliferation; ISO:RGD.
DR   GO; GO:0050853; P:B cell receptor signaling pathway; ISO:RGD.
DR   GO; GO:0001662; P:behavioral fear response; ISO:RGD.
DR   GO; GO:0001658; P:branching involved in ureteric bud morphogenesis; ISO:RGD.
DR   GO; GO:0060402; P:calcium ion transport into cytosol; ISO:RGD.
DR   GO; GO:0043375; P:CD8-positive, alpha-beta T cell lineage commitment; ISO:RGD.
DR   GO; GO:0016477; P:cell migration; ISO:RGD.
DR   GO; GO:0000902; P:cell morphogenesis; ISO:RGD.
DR   GO; GO:0008283; P:cell population proliferation; ISO:RGD.
DR   GO; GO:0098609; P:cell-cell adhesion; ISO:RGD.
DR   GO; GO:1902618; P:cellular response to fluoride; IEP:RGD.
DR   GO; GO:0042149; P:cellular response to glucose starvation; ISO:RGD.
DR   GO; GO:0071333; P:cellular response to glucose stimulus; IEP:RGD.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IEP:RGD.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEP:RGD.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0021987; P:cerebral cortex development; IEP:RGD.
DR   GO; GO:0021747; P:cochlear nucleus development; ISO:RGD.
DR   GO; GO:0051607; P:defense response to virus; ISO:RGD.
DR   GO; GO:0097048; P:dendritic cell apoptotic process; ISO:RGD.
DR   GO; GO:0048589; P:developmental growth; ISO:RGD.
DR   GO; GO:0048066; P:developmental pigmentation; ISO:RGD.
DR   GO; GO:0048546; P:digestive tract morphogenesis; ISO:RGD.
DR   GO; GO:0006974; P:DNA damage response; ISO:RGD.
DR   GO; GO:0043583; P:ear development; ISO:RGD.
DR   GO; GO:0032469; P:endoplasmic reticulum calcium ion homeostasis; ISO:RGD.
DR   GO; GO:1904019; P:epithelial cell apoptotic process; ISO:RGD.
DR   GO; GO:0051649; P:establishment of localization in cell; ISO:RGD.
DR   GO; GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; ISO:RGD.
DR   GO; GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; ISO:RGD.
DR   GO; GO:0048041; P:focal adhesion assembly; ISO:RGD.
DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; ISO:RGD.
DR   GO; GO:0022612; P:gland morphogenesis; ISO:RGD.
DR   GO; GO:0034349; P:glial cell apoptotic process; IEP:RGD.
DR   GO; GO:0032835; P:glomerulus development; ISO:RGD.
DR   GO; GO:0031069; P:hair follicle morphogenesis; ISO:RGD.
DR   GO; GO:0060218; P:hematopoietic stem cell differentiation; ISO:RGD.
DR   GO; GO:0030097; P:hemopoiesis; ISO:RGD.
DR   GO; GO:0048873; P:homeostasis of number of cells within a tissue; ISO:RGD.
DR   GO; GO:0002520; P:immune system development; ISO:RGD.
DR   GO; GO:0006874; P:intracellular calcium ion homeostasis; ISO:RGD.
DR   GO; GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; ISO:RGD.
DR   GO; GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; ISO:RGD.
DR   GO; GO:0008631; P:intrinsic apoptotic signaling pathway in response to oxidative stress; ISO:RGD.
DR   GO; GO:0001822; P:kidney development; ISO:RGD.
DR   GO; GO:0001776; P:leukocyte homeostasis; ISO:RGD.
DR   GO; GO:0097421; P:liver regeneration; IEP:RGD.
DR   GO; GO:0070227; P:lymphocyte apoptotic process; ISO:RGD.
DR   GO; GO:0002260; P:lymphocyte homeostasis; ISO:RGD.
DR   GO; GO:0002320; P:lymphoid progenitor cell differentiation; ISO:RGD.
DR   GO; GO:0008584; P:male gonad development; ISO:RGD.
DR   GO; GO:0006582; P:melanin metabolic process; ISO:RGD.
DR   GO; GO:0030318; P:melanocyte differentiation; ISO:RGD.
DR   GO; GO:0014031; P:mesenchymal cell development; ISO:RGD.
DR   GO; GO:0001656; P:metanephros development; ISO:RGD.
DR   GO; GO:0000278; P:mitotic cell cycle; ISO:RGD.
DR   GO; GO:0097049; P:motor neuron apoptotic process; ISO:RGD.
DR   GO; GO:0033028; P:myeloid cell apoptotic process; ISO:RGD.
DR   GO; GO:2000811; P:negative regulation of anoikis; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IDA:RGD.
DR   GO; GO:2001234; P:negative regulation of apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0010507; P:negative regulation of autophagy; ISS:UniProtKB.
DR   GO; GO:0002903; P:negative regulation of B cell apoptotic process; ISO:RGD.
DR   GO; GO:0010523; P:negative regulation of calcium ion transport into cytosol; ISO:RGD.
DR   GO; GO:0010667; P:negative regulation of cardiac muscle cell apoptotic process; IMP:BHF-UCL.
DR   GO; GO:0030308; P:negative regulation of cell growth; ISO:RGD.
DR   GO; GO:0030336; P:negative regulation of cell migration; ISO:RGD.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0032848; P:negative regulation of cellular pH reduction; ISO:RGD.
DR   GO; GO:2000669; P:negative regulation of dendritic cell apoptotic process; ISO:RGD.
DR   GO; GO:1904036; P:negative regulation of epithelial cell apoptotic process; ISO:RGD.
DR   GO; GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; ISO:RGD.
DR   GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; ISO:RGD.
DR   GO; GO:2001243; P:negative regulation of intrinsic apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0070229; P:negative regulation of lymphocyte apoptotic process; ISO:RGD.
DR   GO; GO:0045930; P:negative regulation of mitotic cell cycle; ISO:RGD.
DR   GO; GO:2000672; P:negative regulation of motor neuron apoptotic process; ISO:RGD.
DR   GO; GO:0033033; P:negative regulation of myeloid cell apoptotic process; ISO:RGD.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; ISO:RGD.
DR   GO; GO:0030279; P:negative regulation of ossification; ISO:RGD.
DR   GO; GO:0033689; P:negative regulation of osteoblast proliferation; ISO:RGD.
DR   GO; GO:2000378; P:negative regulation of reactive oxygen species metabolic process; ISO:RGD.
DR   GO; GO:0046671; P:negative regulation of retinal cell programmed cell death; ISO:RGD.
DR   GO; GO:0070233; P:negative regulation of T cell apoptotic process; ISO:RGD.
DR   GO; GO:0051402; P:neuron apoptotic process; ISO:RGD.
DR   GO; GO:0042551; P:neuron maturation; ISO:RGD.
DR   GO; GO:0048709; P:oligodendrocyte differentiation; IEP:RGD.
DR   GO; GO:0048599; P:oocyte development; ISO:RGD.
DR   GO; GO:0035265; P:organ growth; ISO:RGD.
DR   GO; GO:0001503; P:ossification; ISO:RGD.
DR   GO; GO:0033687; P:osteoblast proliferation; ISO:RGD.
DR   GO; GO:0001541; P:ovarian follicle development; IEP:RGD.
DR   GO; GO:0048753; P:pigment granule organization; ISO:RGD.
DR   GO; GO:0043473; P:pigmentation; ISO:RGD.
DR   GO; GO:0030890; P:positive regulation of B cell proliferation; ISO:RGD.
DR   GO; GO:0030307; P:positive regulation of cell growth; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0048087; P:positive regulation of developmental pigmentation; ISO:RGD.
DR   GO; GO:0045636; P:positive regulation of melanocyte differentiation; ISO:RGD.
DR   GO; GO:0040018; P:positive regulation of multicellular organism growth; ISO:RGD.
DR   GO; GO:0014042; P:positive regulation of neuron maturation; ISO:RGD.
DR   GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; ISO:RGD.
DR   GO; GO:0048743; P:positive regulation of skeletal muscle fiber development; ISO:RGD.
DR   GO; GO:0014911; P:positive regulation of smooth muscle cell migration; ISO:RGD.
DR   GO; GO:0009791; P:post-embryonic development; ISO:RGD.
DR   GO; GO:0000209; P:protein polyubiquitination; ISO:RGD.
DR   GO; GO:0072593; P:reactive oxygen species metabolic process; ISO:RGD.
DR   GO; GO:0042981; P:regulation of apoptotic process; ISO:RGD.
DR   GO; GO:0010506; P:regulation of autophagy; ISO:RGD.
DR   GO; GO:0051924; P:regulation of calcium ion transport; ISO:RGD.
DR   GO; GO:0051726; P:regulation of cell cycle; ISO:RGD.
DR   GO; GO:0001952; P:regulation of cell-matrix adhesion; ISO:RGD.
DR   GO; GO:0048070; P:regulation of developmental pigmentation; ISO:RGD.
DR   GO; GO:0010468; P:regulation of gene expression; ISO:RGD.
DR   GO; GO:0010559; P:regulation of glycoprotein biosynthetic process; ISO:RGD.
DR   GO; GO:0040008; P:regulation of growth; ISO:RGD.
DR   GO; GO:0046902; P:regulation of mitochondrial membrane permeability; ISS:HGNC-UCL.
DR   GO; GO:0051881; P:regulation of mitochondrial membrane potential; ISS:HGNC-UCL.
DR   GO; GO:0006808; P:regulation of nitrogen utilization; ISO:RGD.
DR   GO; GO:0043067; P:regulation of programmed cell death; ISO:RGD.
DR   GO; GO:0032880; P:regulation of protein localization; ISO:RGD.
DR   GO; GO:0031647; P:regulation of protein stability; ISO:RGD.
DR   GO; GO:0045069; P:regulation of viral genome replication; ISO:RGD.
DR   GO; GO:0001836; P:release of cytochrome c from mitochondria; ISS:HGNC-UCL.
DR   GO; GO:0003014; P:renal system process; ISO:RGD.
DR   GO; GO:0010044; P:response to aluminum ion; IEP:RGD.
DR   GO; GO:1904645; P:response to amyloid-beta; IEP:RGD.
DR   GO; GO:0031000; P:response to caffeine; IEP:RGD.
DR   GO; GO:0051591; P:response to cAMP; IEP:RGD.
DR   GO; GO:0046688; P:response to copper ion; IEP:RGD.
DR   GO; GO:0051412; P:response to corticosterone; IEP:RGD.
DR   GO; GO:0034097; P:response to cytokine; IEP:RGD.
DR   GO; GO:0051602; P:response to electrical stimulus; IEP:RGD.
DR   GO; GO:0036017; P:response to erythropoietin; IEP:RGD.
DR   GO; GO:0043627; P:response to estrogen; IEP:RGD.
DR   GO; GO:0045471; P:response to ethanol; IDA:RGD.
DR   GO; GO:0051593; P:response to folic acid; IEP:RGD.
DR   GO; GO:0010332; P:response to gamma radiation; ISO:RGD.
DR   GO; GO:0051384; P:response to glucocorticoid; ISO:RGD.
DR   GO; GO:0042542; P:response to hydrogen peroxide; ISO:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IEP:RGD.
DR   GO; GO:0032868; P:response to insulin; IEP:RGD.
DR   GO; GO:0010039; P:response to iron ion; ISO:RGD.
DR   GO; GO:0002931; P:response to ischemia; IEP:RGD.
DR   GO; GO:0033591; P:response to L-ascorbic acid; IEP:RGD.
DR   GO; GO:0034284; P:response to monosaccharide; IEP:RGD.
DR   GO; GO:0035094; P:response to nicotine; IEP:RGD.
DR   GO; GO:0007584; P:response to nutrient; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0006979; P:response to oxidative stress; ISO:RGD.
DR   GO; GO:0043434; P:response to peptide hormone; IEP:RGD.
DR   GO; GO:0080184; P:response to phenylpropanoid; IEP:RGD.
DR   GO; GO:0048545; P:response to steroid hormone; ISO:RGD.
DR   GO; GO:0009636; P:response to toxic substance; ISO:RGD.
DR   GO; GO:0010224; P:response to UV-B; ISO:RGD.
DR   GO; GO:0033197; P:response to vitamin E; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0046666; P:retinal cell programmed cell death; ISO:RGD.
DR   GO; GO:0048741; P:skeletal muscle fiber development; ISO:RGD.
DR   GO; GO:0014909; P:smooth muscle cell migration; ISO:RGD.
DR   GO; GO:0048536; P:spleen development; ISO:RGD.
DR   GO; GO:0048864; P:stem cell development; ISO:RGD.
DR   GO; GO:0070231; P:T cell apoptotic process; ISO:RGD.
DR   GO; GO:0030217; P:T cell differentiation; ISO:RGD.
DR   GO; GO:0033077; P:T cell differentiation in thymus; ISO:RGD.
DR   GO; GO:0043029; P:T cell homeostasis; ISO:RGD.
DR   GO; GO:0002360; P:T cell lineage commitment; ISO:RGD.
DR   GO; GO:0048538; P:thymus development; ISO:RGD.
DR   GO; GO:0001657; P:ureteric bud development; ISO:RGD.
DR   CDD; cd06845; Bcl-2_like; 1.
DR   Gene3D; 1.10.437.10; Blc2-like; 1.
DR   InterPro; IPR013278; Apop_reg_Bcl2.
DR   InterPro; IPR036834; Bcl-2-like_sf.
DR   InterPro; IPR046371; Bcl-2_BH1-3.
DR   InterPro; IPR026298; Bcl-2_fam.
DR   InterPro; IPR002475; Bcl2-like.
DR   InterPro; IPR004725; Bcl2/BclX.
DR   InterPro; IPR020717; Bcl2_BH1_motif_CS.
DR   InterPro; IPR020726; Bcl2_BH2_motif_CS.
DR   InterPro; IPR020728; Bcl2_BH3_motif_CS.
DR   InterPro; IPR003093; Bcl2_BH4.
DR   InterPro; IPR020731; Bcl2_BH4_motif_CS.
DR   NCBIfam; TIGR00865; bcl-2; 1.
DR   PANTHER; PTHR11256:SF60; APOPTOSIS REGULATOR BCL-2; 1.
DR   PANTHER; PTHR11256; BCL-2 RELATED; 1.
DR   Pfam; PF00452; Bcl-2; 1.
DR   Pfam; PF02180; BH4; 1.
DR   PRINTS; PR01863; APOPREGBCL2.
DR   PRINTS; PR01862; BCL2FAMILY.
DR   SMART; SM00337; BCL; 1.
DR   SMART; SM00265; BH4; 1.
DR   SUPFAM; SSF56854; Bcl-2 inhibitors of programmed cell death; 1.
DR   PROSITE; PS50062; BCL2_FAMILY; 1.
DR   PROSITE; PS01080; BH1; 1.
DR   PROSITE; PS01258; BH2; 1.
DR   PROSITE; PS01259; BH3; 1.
DR   PROSITE; PS01260; BH4_1; 1.
DR   PROSITE; PS50063; BH4_2; 1.
PE   1: Evidence at protein level;
KW   Apoptosis; Autophagy; Cytoplasm; Endoplasmic reticulum; Membrane;
KW   Mitochondrion; Mitochondrion outer membrane; Nucleus; Phosphoprotein;
KW   Reference proteome; Transmembrane; Transmembrane helix; Ubl conjugation.
FT   CHAIN           1..236
FT                   /note="Apoptosis regulator Bcl-2"
FT                   /id="PRO_0000143050"
FT   TRANSMEM        209..230
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   MOTIF           10..30
FT                   /note="BH4"
FT   MOTIF           90..104
FT                   /note="BH3"
FT   MOTIF           133..152
FT                   /note="BH1"
FT   MOTIF           184..199
FT                   /note="BH2"
FT   SITE            34..35
FT                   /note="Cleavage; by caspases"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         69
FT                   /note="Phosphothreonine; by MAPK8"
FT                   /evidence="ECO:0000250|UniProtKB:P10415"
FT   MOD_RES         70
FT                   /note="Phosphoserine; by MAPK8 and PKC"
FT                   /evidence="ECO:0000250|UniProtKB:P10415"
FT   MOD_RES         84
FT                   /note="Phosphoserine; by MAPK8"
FT                   /evidence="ECO:0000250|UniProtKB:P10415"
FT   CONFLICT        42
FT                   /note="A -> R (in Ref. 2; AAA77687)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        157
FT                   /note="E -> G (in Ref. 1; AAA53662)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        164
FT                   /note="S -> Y (in Ref. 2; AAA77687)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        212
FT                   /note="L -> Q (in Ref. 2; AAA77687)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   236 AA;  26622 MW;  E7688CB9071A872A CRC64;
     MAQAGRTGYD NREIVMKYIH YKLSQRGYEW DTGDEDSAPL RAAPTPGIFS FQPESNRTPA
     VHRDTAARTS PLRPLVANAG PALSPVPPVV HLTLRRAGDD FSRRYRRDFA EMSSQLHLTP
     FTARGRFATV VEELFRDGVN WGRIVAFFEF GGVMCVESVN REMSPLVDNI ALWMTEYLNR
     HLHTWIQDNG GWDAFVELYG PSMRPLFDFS WLSLKTLLSL ALVGACITLG AYLGHK
//
